Epigenomics-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1103727, encodeId=cf7b1103e27fa, content=选刊时有哪些需要避免的雷区？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103728, encodeId=b3691103e28d8, content=哪些期刊是公认的水刊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080559, encodeId=b1481080559a3, content=偏重的研究方向：生物信息学 经验分享：拒稿率高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16645573724, createdName=yongshuang, createdTime=Thu Dec 16 08:58:35 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014215, encodeId=5e6c101421588, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：表观遗传;生信 经验分享：想知道不加速的话全流程得多久啊····, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=24591642868, createdName=sunnysx, createdTime=Fri Sep 03 09:39:18 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579984, encodeId=13c85e998471, content=不开放获取可以不交版面费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06a41689219, createdName=momoxiaogu, createdTime=Sat Nov 16 00:00:00 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944688, encodeId=c2469446887d, content=请问各位，如果没选择加速出版的话一般一审多久？我1月份投稿，未选择加速出版和开源，投稿一周后状态从under consideration变成under review，现在under review状态持续差不多四周了，还是一点动静没有。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78ee5383123, createdName=ms7000000876347523, createdTime=Tue Mar 02 10:25:13 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=949586, encodeId=1c839495860a, content=请问各位大神，投稿5天，一直处于under consideration~是怎么个意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e3ad5471158, createdName=ms2000001884403772, createdTime=Fri Mar 19 21:23:49 CST 2021, time=2021-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905919, encodeId=8356905919c0, content=Please amend the author disclosure form to complete section 8 and return this to the journal via email (c.brady@futuremedicine.com. 请问各位大佬文章接收后收到编辑发来的邮件说要这个东西，要怎么弄，这个表格去哪里下载。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bd685266604, createdName=一年发三篇, createdTime=Tue Dec 08 09:53:16 CST 2020, time=2020-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=809982, encodeId=960a809982df, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：主要内容是表观遗传，加小的实验验证 2020.5.11-投稿，选择了加速 2020.5.28-修回R1-小修-一周内修回 2020.6.5-修回去 2020.6.11-再次修回R2,小修，主要是修改文章里面的试剂厂家以及个别语句 2020.6.14修回去 2020.6.16 接收，让交钱 2020.6.23发给proof（无图片，说图片正在修），让修改 2020.6.24修改好了proof，提交了 2020.7.1，说缺少了一张图figure 5，让补充，由于老板没及时check邮件，7.9号发给我，在7.9号补充，返回去了 2020.7.18，再次给了proof，带上了图片 2020.7.18，proof基本没问题就提交了 2020.7.23，online 历经2个多月，供大家参考！<a href='/topic/show?id=4f77e665253' target=_blank style='color:#2F92EE;'><a href='/topic/show?id=4f77e665253' target=_blank style='color:#2F92EE;'>#糖尿病#</a></a><a href='/topic/show?id=4f77e665253' target=_blank style='color:#2F92EE;'><a href='/topic/show?id=4f77e665253' target=_blank style='color:#2F92EE;'>#糖尿病#</a></a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=750, replyNumber=8, topicName=null, topicId=null, topicList=[TopicDto(id=76652, encryptionId=4f77e665253, topicName=糖尿病)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/SHS7K7Rw2Xj3oIen70BqdRFHOB0Y2iaQ14FZw2TCsgCVD3dL2xAQ38zAshDcFPWhNtFPDXCZo9libNK4wqT2Cicgw/132, createdBy=de1b5291100, createdName=With_yan, createdTime=Tue Aug 18 08:27:36 CST 2020, time=2020-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591318, encodeId=efdc591318e6, content=只要能快点审完就行With_yan 2020-05-20 发表:: 我是5.11提交的，一开始是under consideration，现在是under review，under review这个状态两三天了。很奇怪为啥咱们不一样With_yan 2020-05-20 00:00:00 发表: 我是5.11提交的，一开始是under consideration，现在是under review，under review这个状态两三天了。很奇怪为啥咱们不一样, beContent=With_yan 2020-05-20 发表:: 我是5.11提交的，一开始是under consideration，现在是under review，under review这个状态两三天了。很奇怪为啥咱们不一样, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24355093072, createdName=145d9400m83暂无昵称, createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=)]

2021-12-28 小动量

选刊时有哪些需要避免的雷区？

49 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1103727, encodeId=cf7b1103e27fa, content=选刊时有哪些需要避免的雷区？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103728, encodeId=b3691103e28d8, content=哪些期刊是公认的水刊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080559, encodeId=b1481080559a3, content=偏重的研究方向：生物信息学 经验分享：拒稿率高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16645573724, createdName=yongshuang, createdTime=Thu Dec 16 08:58:35 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014215, encodeId=5e6c101421588, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：表观遗传;生信 经验分享：想知道不加速的话全流程得多久啊····, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=24591642868, createdName=sunnysx, createdTime=Fri Sep 03 09:39:18 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579984, encodeId=13c85e998471, content=不开放获取可以不交版面费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06a41689219, createdName=momoxiaogu, createdTime=Sat Nov 16 00:00:00 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944688, encodeId=c2469446887d, content=请问各位，如果没选择加速出版的话一般一审多久？我1月份投稿，未选择加速出版和开源，投稿一周后状态从under consideration变成under review，现在under review状态持续差不多四周了，还是一点动静没有。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78ee5383123, createdName=ms7000000876347523, createdTime=Tue Mar 02 10:25:13 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=949586, encodeId=1c839495860a, content=请问各位大神，投稿5天，一直处于under consideration~是怎么个意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e3ad5471158, createdName=ms2000001884403772, createdTime=Fri Mar 19 21:23:49 CST 2021, time=2021-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905919, encodeId=8356905919c0, content=Please amend the author disclosure form to complete section 8 and return this to the journal via email (c.brady@futuremedicine.com. 请问各位大佬文章接收后收到编辑发来的邮件说要这个东西，要怎么弄，这个表格去哪里下载。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bd685266604, createdName=一年发三篇, createdTime=Tue Dec 08 09:53:16 CST 2020, time=2020-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=809982, encodeId=960a809982df, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：主要内容是表观遗传，加小的实验验证 2020.5.11-投稿，选择了加速 2020.5.28-修回R1-小修-一周内修回 2020.6.5-修回去 2020.6.11-再次修回R2,小修，主要是修改文章里面的试剂厂家以及个别语句 2020.6.14修回去 2020.6.16 接收，让交钱 2020.6.23发给proof（无图片，说图片正在修），让修改 2020.6.24修改好了proof，提交了 2020.7.1，说缺少了一张图figure 5，让补充，由于老板没及时check邮件，7.9号发给我，在7.9号补充，返回去了 2020.7.18，再次给了proof，带上了图片 2020.7.18，proof基本没问题就提交了 2020.7.23，online 历经2个多月，供大家参考！<a href='/topic/show?id=4f77e665253' target=_blank style='color:#2F92EE;'><a href='/topic/show?id=4f77e665253' target=_blank style='color:#2F92EE;'>#糖尿病#</a></a><a href='/topic/show?id=4f77e665253' target=_blank style='color:#2F92EE;'><a href='/topic/show?id=4f77e665253' target=_blank style='color:#2F92EE;'>#糖尿病#</a></a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=750, replyNumber=8, topicName=null, topicId=null, topicList=[TopicDto(id=76652, encryptionId=4f77e665253, topicName=糖尿病)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/SHS7K7Rw2Xj3oIen70BqdRFHOB0Y2iaQ14FZw2TCsgCVD3dL2xAQ38zAshDcFPWhNtFPDXCZo9libNK4wqT2Cicgw/132, createdBy=de1b5291100, createdName=With_yan, createdTime=Tue Aug 18 08:27:36 CST 2020, time=2020-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591318, encodeId=efdc591318e6, content=只要能快点审完就行With_yan 2020-05-20 发表:: 我是5.11提交的，一开始是under consideration，现在是under review，under review这个状态两三天了。很奇怪为啥咱们不一样With_yan 2020-05-20 00:00:00 发表: 我是5.11提交的，一开始是under consideration，现在是under review，under review这个状态两三天了。很奇怪为啥咱们不一样, beContent=With_yan 2020-05-20 发表:: 我是5.11提交的，一开始是under consideration，现在是under review，under review这个状态两三天了。很奇怪为啥咱们不一样, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24355093072, createdName=145d9400m83暂无昵称, createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=)]

2021-12-28 乌云背后的幸福线

哪些期刊是公认的水刊？

51 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1103727, encodeId=cf7b1103e27fa, content=选刊时有哪些需要避免的雷区？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103728, encodeId=b3691103e28d8, content=哪些期刊是公认的水刊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080559, encodeId=b1481080559a3, content=偏重的研究方向：生物信息学 经验分享：拒稿率高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16645573724, createdName=yongshuang, createdTime=Thu Dec 16 08:58:35 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014215, encodeId=5e6c101421588, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：表观遗传;生信 经验分享：想知道不加速的话全流程得多久啊····, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=24591642868, createdName=sunnysx, createdTime=Fri Sep 03 09:39:18 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579984, encodeId=13c85e998471, content=不开放获取可以不交版面费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06a41689219, createdName=momoxiaogu, createdTime=Sat Nov 16 00:00:00 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944688, encodeId=c2469446887d, content=请问各位，如果没选择加速出版的话一般一审多久？我1月份投稿，未选择加速出版和开源，投稿一周后状态从under consideration变成under review，现在under review状态持续差不多四周了，还是一点动静没有。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78ee5383123, createdName=ms7000000876347523, createdTime=Tue Mar 02 10:25:13 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=949586, encodeId=1c839495860a, content=请问各位大神，投稿5天，一直处于under consideration~是怎么个意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e3ad5471158, createdName=ms2000001884403772, createdTime=Fri Mar 19 21:23:49 CST 2021, time=2021-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905919, encodeId=8356905919c0, content=Please amend the author disclosure form to complete section 8 and return this to the journal via email (c.brady@futuremedicine.com. 请问各位大佬文章接收后收到编辑发来的邮件说要这个东西，要怎么弄，这个表格去哪里下载。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bd685266604, createdName=一年发三篇, createdTime=Tue Dec 08 09:53:16 CST 2020, time=2020-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=809982, encodeId=960a809982df, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：主要内容是表观遗传，加小的实验验证 2020.5.11-投稿，选择了加速 2020.5.28-修回R1-小修-一周内修回 2020.6.5-修回去 2020.6.11-再次修回R2,小修，主要是修改文章里面的试剂厂家以及个别语句 2020.6.14修回去 2020.6.16 接收，让交钱 2020.6.23发给proof（无图片，说图片正在修），让修改 2020.6.24修改好了proof，提交了 2020.7.1，说缺少了一张图figure 5，让补充，由于老板没及时check邮件，7.9号发给我，在7.9号补充，返回去了 2020.7.18，再次给了proof，带上了图片 2020.7.18，proof基本没问题就提交了 2020.7.23，online 历经2个多月，供大家参考！<a href='/topic/show?id=4f77e665253' target=_blank style='color:#2F92EE;'><a href='/topic/show?id=4f77e665253' target=_blank style='color:#2F92EE;'>#糖尿病#</a></a><a href='/topic/show?id=4f77e665253' target=_blank style='color:#2F92EE;'><a href='/topic/show?id=4f77e665253' target=_blank style='color:#2F92EE;'>#糖尿病#</a></a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=750, replyNumber=8, topicName=null, topicId=null, topicList=[TopicDto(id=76652, encryptionId=4f77e665253, topicName=糖尿病)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/SHS7K7Rw2Xj3oIen70BqdRFHOB0Y2iaQ14FZw2TCsgCVD3dL2xAQ38zAshDcFPWhNtFPDXCZo9libNK4wqT2Cicgw/132, createdBy=de1b5291100, createdName=With_yan, createdTime=Tue Aug 18 08:27:36 CST 2020, time=2020-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591318, encodeId=efdc591318e6, content=只要能快点审完就行With_yan 2020-05-20 发表:: 我是5.11提交的，一开始是under consideration，现在是under review，under review这个状态两三天了。很奇怪为啥咱们不一样With_yan 2020-05-20 00:00:00 发表: 我是5.11提交的，一开始是under consideration，现在是under review，under review这个状态两三天了。很奇怪为啥咱们不一样, beContent=With_yan 2020-05-20 发表:: 我是5.11提交的，一开始是under consideration，现在是under review，under review这个状态两三天了。很奇怪为啥咱们不一样, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24355093072, createdName=145d9400m83暂无昵称, createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=)]

2021-12-16 yongshuang

偏重的研究方向：生物信息学
经验分享：拒稿率高

52 0

[GetPortalCommentsPageByObjectIdResponse(id=1103727, encodeId=cf7b1103e27fa, content=选刊时有哪些需要避免的雷区？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103728, encodeId=b3691103e28d8, content=哪些期刊是公认的水刊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080559, encodeId=b1481080559a3, content=偏重的研究方向：生物信息学 经验分享：拒稿率高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16645573724, createdName=yongshuang, createdTime=Thu Dec 16 08:58:35 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014215, encodeId=5e6c101421588, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：表观遗传;生信 经验分享：想知道不加速的话全流程得多久啊····, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=24591642868, createdName=sunnysx, createdTime=Fri Sep 03 09:39:18 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579984, encodeId=13c85e998471, content=不开放获取可以不交版面费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06a41689219, createdName=momoxiaogu, createdTime=Sat Nov 16 00:00:00 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944688, encodeId=c2469446887d, content=请问各位，如果没选择加速出版的话一般一审多久？我1月份投稿，未选择加速出版和开源，投稿一周后状态从under consideration变成under review，现在under review状态持续差不多四周了，还是一点动静没有。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78ee5383123, createdName=ms7000000876347523, createdTime=Tue Mar 02 10:25:13 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=949586, encodeId=1c839495860a, content=请问各位大神，投稿5天，一直处于under consideration~是怎么个意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e3ad5471158, createdName=ms2000001884403772, createdTime=Fri Mar 19 21:23:49 CST 2021, time=2021-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905919, encodeId=8356905919c0, content=Please amend the author disclosure form to complete section 8 and return this to the journal via email (c.brady@futuremedicine.com. 请问各位大佬文章接收后收到编辑发来的邮件说要这个东西，要怎么弄，这个表格去哪里下载。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bd685266604, createdName=一年发三篇, createdTime=Tue Dec 08 09:53:16 CST 2020, time=2020-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=809982, encodeId=960a809982df, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：主要内容是表观遗传，加小的实验验证 2020.5.11-投稿，选择了加速 2020.5.28-修回R1-小修-一周内修回 2020.6.5-修回去 2020.6.11-再次修回R2,小修，主要是修改文章里面的试剂厂家以及个别语句 2020.6.14修回去 2020.6.16 接收，让交钱 2020.6.23发给proof（无图片，说图片正在修），让修改 2020.6.24修改好了proof，提交了 2020.7.1，说缺少了一张图figure 5，让补充，由于老板没及时check邮件，7.9号发给我，在7.9号补充，返回去了 2020.7.18，再次给了proof，带上了图片 2020.7.18，proof基本没问题就提交了 2020.7.23，online 历经2个多月，供大家参考！<a href='/topic/show?id=4f77e665253' target=_blank style='color:#2F92EE;'><a href='/topic/show?id=4f77e665253' target=_blank style='color:#2F92EE;'>#糖尿病#</a></a><a href='/topic/show?id=4f77e665253' target=_blank style='color:#2F92EE;'><a href='/topic/show?id=4f77e665253' target=_blank style='color:#2F92EE;'>#糖尿病#</a></a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=750, replyNumber=8, topicName=null, topicId=null, topicList=[TopicDto(id=76652, encryptionId=4f77e665253, topicName=糖尿病)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/SHS7K7Rw2Xj3oIen70BqdRFHOB0Y2iaQ14FZw2TCsgCVD3dL2xAQ38zAshDcFPWhNtFPDXCZo9libNK4wqT2Cicgw/132, createdBy=de1b5291100, createdName=With_yan, createdTime=Tue Aug 18 08:27:36 CST 2020, time=2020-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591318, encodeId=efdc591318e6, content=只要能快点审完就行With_yan 2020-05-20 发表:: 我是5.11提交的，一开始是under consideration，现在是under review，under review这个状态两三天了。很奇怪为啥咱们不一样With_yan 2020-05-20 00:00:00 发表: 我是5.11提交的，一开始是under consideration，现在是under review，under review这个状态两三天了。很奇怪为啥咱们不一样, beContent=With_yan 2020-05-20 发表:: 我是5.11提交的，一开始是under consideration，现在是under review，under review这个状态两三天了。很奇怪为啥咱们不一样, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24355093072, createdName=145d9400m83暂无昵称, createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=)]

2021-09-03 sunnysx

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：表观遗传;生信
经验分享：想知道不加速的话全流程得多久啊····

50 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1103727, encodeId=cf7b1103e27fa, content=选刊时有哪些需要避免的雷区？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103728, encodeId=b3691103e28d8, content=哪些期刊是公认的水刊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080559, encodeId=b1481080559a3, content=偏重的研究方向：生物信息学 经验分享：拒稿率高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16645573724, createdName=yongshuang, createdTime=Thu Dec 16 08:58:35 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014215, encodeId=5e6c101421588, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：表观遗传;生信 经验分享：想知道不加速的话全流程得多久啊····, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=24591642868, createdName=sunnysx, createdTime=Fri Sep 03 09:39:18 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579984, encodeId=13c85e998471, content=不开放获取可以不交版面费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06a41689219, createdName=momoxiaogu, createdTime=Sat Nov 16 00:00:00 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944688, encodeId=c2469446887d, content=请问各位，如果没选择加速出版的话一般一审多久？我1月份投稿，未选择加速出版和开源，投稿一周后状态从under consideration变成under review，现在under review状态持续差不多四周了，还是一点动静没有。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78ee5383123, createdName=ms7000000876347523, createdTime=Tue Mar 02 10:25:13 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=949586, encodeId=1c839495860a, content=请问各位大神，投稿5天，一直处于under consideration~是怎么个意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e3ad5471158, createdName=ms2000001884403772, createdTime=Fri Mar 19 21:23:49 CST 2021, time=2021-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905919, encodeId=8356905919c0, content=Please amend the author disclosure form to complete section 8 and return this to the journal via email (c.brady@futuremedicine.com. 请问各位大佬文章接收后收到编辑发来的邮件说要这个东西，要怎么弄，这个表格去哪里下载。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bd685266604, createdName=一年发三篇, createdTime=Tue Dec 08 09:53:16 CST 2020, time=2020-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=809982, encodeId=960a809982df, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：主要内容是表观遗传，加小的实验验证 2020.5.11-投稿，选择了加速 2020.5.28-修回R1-小修-一周内修回 2020.6.5-修回去 2020.6.11-再次修回R2,小修，主要是修改文章里面的试剂厂家以及个别语句 2020.6.14修回去 2020.6.16 接收，让交钱 2020.6.23发给proof（无图片，说图片正在修），让修改 2020.6.24修改好了proof，提交了 2020.7.1，说缺少了一张图figure 5，让补充，由于老板没及时check邮件，7.9号发给我，在7.9号补充，返回去了 2020.7.18，再次给了proof，带上了图片 2020.7.18，proof基本没问题就提交了 2020.7.23，online 历经2个多月，供大家参考！<a href='/topic/show?id=4f77e665253' target=_blank style='color:#2F92EE;'><a href='/topic/show?id=4f77e665253' target=_blank style='color:#2F92EE;'>#糖尿病#</a></a><a href='/topic/show?id=4f77e665253' target=_blank style='color:#2F92EE;'><a href='/topic/show?id=4f77e665253' target=_blank style='color:#2F92EE;'>#糖尿病#</a></a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=750, replyNumber=8, topicName=null, topicId=null, topicList=[TopicDto(id=76652, encryptionId=4f77e665253, topicName=糖尿病)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/SHS7K7Rw2Xj3oIen70BqdRFHOB0Y2iaQ14FZw2TCsgCVD3dL2xAQ38zAshDcFPWhNtFPDXCZo9libNK4wqT2Cicgw/132, createdBy=de1b5291100, createdName=With_yan, createdTime=Tue Aug 18 08:27:36 CST 2020, time=2020-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591318, encodeId=efdc591318e6, content=只要能快点审完就行With_yan 2020-05-20 发表:: 我是5.11提交的，一开始是under consideration，现在是under review，under review这个状态两三天了。很奇怪为啥咱们不一样With_yan 2020-05-20 00:00:00 发表: 我是5.11提交的，一开始是under consideration，现在是under review，under review这个状态两三天了。很奇怪为啥咱们不一样, beContent=With_yan 2020-05-20 发表:: 我是5.11提交的，一开始是under consideration，现在是under review，under review这个状态两三天了。很奇怪为啥咱们不一样, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24355093072, createdName=145d9400m83暂无昵称, createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=)]

2019-11-16 momoxiaogu

不开放获取可以不交版面费吗？

127 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1103727, encodeId=cf7b1103e27fa, content=选刊时有哪些需要避免的雷区？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103728, encodeId=b3691103e28d8, content=哪些期刊是公认的水刊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080559, encodeId=b1481080559a3, content=偏重的研究方向：生物信息学 经验分享：拒稿率高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16645573724, createdName=yongshuang, createdTime=Thu Dec 16 08:58:35 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014215, encodeId=5e6c101421588, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：表观遗传;生信 经验分享：想知道不加速的话全流程得多久啊····, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=24591642868, createdName=sunnysx, createdTime=Fri Sep 03 09:39:18 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579984, encodeId=13c85e998471, content=不开放获取可以不交版面费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06a41689219, createdName=momoxiaogu, createdTime=Sat Nov 16 00:00:00 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944688, encodeId=c2469446887d, content=请问各位，如果没选择加速出版的话一般一审多久？我1月份投稿，未选择加速出版和开源，投稿一周后状态从under consideration变成under review，现在under review状态持续差不多四周了，还是一点动静没有。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78ee5383123, createdName=ms7000000876347523, createdTime=Tue Mar 02 10:25:13 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=949586, encodeId=1c839495860a, content=请问各位大神，投稿5天，一直处于under consideration~是怎么个意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e3ad5471158, createdName=ms2000001884403772, createdTime=Fri Mar 19 21:23:49 CST 2021, time=2021-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905919, encodeId=8356905919c0, content=Please amend the author disclosure form to complete section 8 and return this to the journal via email (c.brady@futuremedicine.com. 请问各位大佬文章接收后收到编辑发来的邮件说要这个东西，要怎么弄，这个表格去哪里下载。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bd685266604, createdName=一年发三篇, createdTime=Tue Dec 08 09:53:16 CST 2020, time=2020-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=809982, encodeId=960a809982df, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：主要内容是表观遗传，加小的实验验证 2020.5.11-投稿，选择了加速 2020.5.28-修回R1-小修-一周内修回 2020.6.5-修回去 2020.6.11-再次修回R2,小修，主要是修改文章里面的试剂厂家以及个别语句 2020.6.14修回去 2020.6.16 接收，让交钱 2020.6.23发给proof（无图片，说图片正在修），让修改 2020.6.24修改好了proof，提交了 2020.7.1，说缺少了一张图figure 5，让补充，由于老板没及时check邮件，7.9号发给我，在7.9号补充，返回去了 2020.7.18，再次给了proof，带上了图片 2020.7.18，proof基本没问题就提交了 2020.7.23，online 历经2个多月，供大家参考！<a href='/topic/show?id=4f77e665253' target=_blank style='color:#2F92EE;'><a href='/topic/show?id=4f77e665253' target=_blank style='color:#2F92EE;'>#糖尿病#</a></a><a href='/topic/show?id=4f77e665253' target=_blank style='color:#2F92EE;'><a href='/topic/show?id=4f77e665253' target=_blank style='color:#2F92EE;'>#糖尿病#</a></a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=750, replyNumber=8, topicName=null, topicId=null, topicList=[TopicDto(id=76652, encryptionId=4f77e665253, topicName=糖尿病)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/SHS7K7Rw2Xj3oIen70BqdRFHOB0Y2iaQ14FZw2TCsgCVD3dL2xAQ38zAshDcFPWhNtFPDXCZo9libNK4wqT2Cicgw/132, createdBy=de1b5291100, createdName=With_yan, createdTime=Tue Aug 18 08:27:36 CST 2020, time=2020-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591318, encodeId=efdc591318e6, content=只要能快点审完就行With_yan 2020-05-20 发表:: 我是5.11提交的，一开始是under consideration，现在是under review，under review这个状态两三天了。很奇怪为啥咱们不一样With_yan 2020-05-20 00:00:00 发表: 我是5.11提交的，一开始是under consideration，现在是under review，under review这个状态两三天了。很奇怪为啥咱们不一样, beContent=With_yan 2020-05-20 发表:: 我是5.11提交的，一开始是under consideration，现在是under review，under review这个状态两三天了。很奇怪为啥咱们不一样, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24355093072, createdName=145d9400m83暂无昵称, createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=)]

2021-03-02 ms7000000876347523

请问各位，如果没选择加速出版的话一般一审多久？我1月份投稿，未选择加速出版和开源，投稿一周后状态从under consideration变成under review，现在under review状态持续差不多四周了，还是一点动静没有。

103 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1103727, encodeId=cf7b1103e27fa, content=选刊时有哪些需要避免的雷区？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103728, encodeId=b3691103e28d8, content=哪些期刊是公认的水刊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080559, encodeId=b1481080559a3, content=偏重的研究方向：生物信息学 经验分享：拒稿率高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16645573724, createdName=yongshuang, createdTime=Thu Dec 16 08:58:35 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014215, encodeId=5e6c101421588, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：表观遗传;生信 经验分享：想知道不加速的话全流程得多久啊····, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=24591642868, createdName=sunnysx, createdTime=Fri Sep 03 09:39:18 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579984, encodeId=13c85e998471, content=不开放获取可以不交版面费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06a41689219, createdName=momoxiaogu, createdTime=Sat Nov 16 00:00:00 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944688, encodeId=c2469446887d, content=请问各位，如果没选择加速出版的话一般一审多久？我1月份投稿，未选择加速出版和开源，投稿一周后状态从under consideration变成under review，现在under review状态持续差不多四周了，还是一点动静没有。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78ee5383123, createdName=ms7000000876347523, createdTime=Tue Mar 02 10:25:13 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=949586, encodeId=1c839495860a, content=请问各位大神，投稿5天，一直处于under consideration~是怎么个意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e3ad5471158, createdName=ms2000001884403772, createdTime=Fri Mar 19 21:23:49 CST 2021, time=2021-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905919, encodeId=8356905919c0, content=Please amend the author disclosure form to complete section 8 and return this to the journal via email (c.brady@futuremedicine.com. 请问各位大佬文章接收后收到编辑发来的邮件说要这个东西，要怎么弄，这个表格去哪里下载。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bd685266604, createdName=一年发三篇, createdTime=Tue Dec 08 09:53:16 CST 2020, time=2020-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=809982, encodeId=960a809982df, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：主要内容是表观遗传，加小的实验验证 2020.5.11-投稿，选择了加速 2020.5.28-修回R1-小修-一周内修回 2020.6.5-修回去 2020.6.11-再次修回R2,小修，主要是修改文章里面的试剂厂家以及个别语句 2020.6.14修回去 2020.6.16 接收，让交钱 2020.6.23发给proof（无图片，说图片正在修），让修改 2020.6.24修改好了proof，提交了 2020.7.1，说缺少了一张图figure 5，让补充，由于老板没及时check邮件，7.9号发给我，在7.9号补充，返回去了 2020.7.18，再次给了proof，带上了图片 2020.7.18，proof基本没问题就提交了 2020.7.23，online 历经2个多月，供大家参考！<a href='/topic/show?id=4f77e665253' target=_blank style='color:#2F92EE;'><a href='/topic/show?id=4f77e665253' target=_blank style='color:#2F92EE;'>#糖尿病#</a></a><a href='/topic/show?id=4f77e665253' target=_blank style='color:#2F92EE;'><a href='/topic/show?id=4f77e665253' target=_blank style='color:#2F92EE;'>#糖尿病#</a></a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=750, replyNumber=8, topicName=null, topicId=null, topicList=[TopicDto(id=76652, encryptionId=4f77e665253, topicName=糖尿病)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/SHS7K7Rw2Xj3oIen70BqdRFHOB0Y2iaQ14FZw2TCsgCVD3dL2xAQ38zAshDcFPWhNtFPDXCZo9libNK4wqT2Cicgw/132, createdBy=de1b5291100, createdName=With_yan, createdTime=Tue Aug 18 08:27:36 CST 2020, time=2020-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591318, encodeId=efdc591318e6, content=只要能快点审完就行With_yan 2020-05-20 发表:: 我是5.11提交的，一开始是under consideration，现在是under review，under review这个状态两三天了。很奇怪为啥咱们不一样With_yan 2020-05-20 00:00:00 发表: 我是5.11提交的，一开始是under consideration，现在是under review，under review这个状态两三天了。很奇怪为啥咱们不一样, beContent=With_yan 2020-05-20 发表:: 我是5.11提交的，一开始是under consideration，现在是under review，under review这个状态两三天了。很奇怪为啥咱们不一样, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24355093072, createdName=145d9400m83暂无昵称, createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=)]

2021-03-19 ms2000001884403772

请问各位大神，投稿5天，一直处于under consideration~是怎么个意思？

74 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1103727, encodeId=cf7b1103e27fa, content=选刊时有哪些需要避免的雷区？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103728, encodeId=b3691103e28d8, content=哪些期刊是公认的水刊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080559, encodeId=b1481080559a3, content=偏重的研究方向：生物信息学 经验分享：拒稿率高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16645573724, createdName=yongshuang, createdTime=Thu Dec 16 08:58:35 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014215, encodeId=5e6c101421588, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：表观遗传;生信 经验分享：想知道不加速的话全流程得多久啊····, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=24591642868, createdName=sunnysx, createdTime=Fri Sep 03 09:39:18 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579984, encodeId=13c85e998471, content=不开放获取可以不交版面费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06a41689219, createdName=momoxiaogu, createdTime=Sat Nov 16 00:00:00 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944688, encodeId=c2469446887d, content=请问各位，如果没选择加速出版的话一般一审多久？我1月份投稿，未选择加速出版和开源，投稿一周后状态从under consideration变成under review，现在under review状态持续差不多四周了，还是一点动静没有。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78ee5383123, createdName=ms7000000876347523, createdTime=Tue Mar 02 10:25:13 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=949586, encodeId=1c839495860a, content=请问各位大神，投稿5天，一直处于under consideration~是怎么个意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e3ad5471158, createdName=ms2000001884403772, createdTime=Fri Mar 19 21:23:49 CST 2021, time=2021-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905919, encodeId=8356905919c0, content=Please amend the author disclosure form to complete section 8 and return this to the journal via email (c.brady@futuremedicine.com. 请问各位大佬文章接收后收到编辑发来的邮件说要这个东西，要怎么弄，这个表格去哪里下载。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bd685266604, createdName=一年发三篇, createdTime=Tue Dec 08 09:53:16 CST 2020, time=2020-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=809982, encodeId=960a809982df, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：主要内容是表观遗传，加小的实验验证 2020.5.11-投稿，选择了加速 2020.5.28-修回R1-小修-一周内修回 2020.6.5-修回去 2020.6.11-再次修回R2,小修，主要是修改文章里面的试剂厂家以及个别语句 2020.6.14修回去 2020.6.16 接收，让交钱 2020.6.23发给proof（无图片，说图片正在修），让修改 2020.6.24修改好了proof，提交了 2020.7.1，说缺少了一张图figure 5，让补充，由于老板没及时check邮件，7.9号发给我，在7.9号补充，返回去了 2020.7.18，再次给了proof，带上了图片 2020.7.18，proof基本没问题就提交了 2020.7.23，online 历经2个多月，供大家参考！<a href='/topic/show?id=4f77e665253' target=_blank style='color:#2F92EE;'><a href='/topic/show?id=4f77e665253' target=_blank style='color:#2F92EE;'>#糖尿病#</a></a><a href='/topic/show?id=4f77e665253' target=_blank style='color:#2F92EE;'><a href='/topic/show?id=4f77e665253' target=_blank style='color:#2F92EE;'>#糖尿病#</a></a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=750, replyNumber=8, topicName=null, topicId=null, topicList=[TopicDto(id=76652, encryptionId=4f77e665253, topicName=糖尿病)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/SHS7K7Rw2Xj3oIen70BqdRFHOB0Y2iaQ14FZw2TCsgCVD3dL2xAQ38zAshDcFPWhNtFPDXCZo9libNK4wqT2Cicgw/132, createdBy=de1b5291100, createdName=With_yan, createdTime=Tue Aug 18 08:27:36 CST 2020, time=2020-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591318, encodeId=efdc591318e6, content=只要能快点审完就行With_yan 2020-05-20 发表:: 我是5.11提交的，一开始是under consideration，现在是under review，under review这个状态两三天了。很奇怪为啥咱们不一样With_yan 2020-05-20 00:00:00 发表: 我是5.11提交的，一开始是under consideration，现在是under review，under review这个状态两三天了。很奇怪为啥咱们不一样, beContent=With_yan 2020-05-20 发表:: 我是5.11提交的，一开始是under consideration，现在是under review，under review这个状态两三天了。很奇怪为啥咱们不一样, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24355093072, createdName=145d9400m83暂无昵称, createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=)]

2020-12-08 一年发三篇

Please amend the author disclosure form to complete section 8 and return this to the journal via email (c.brady@futuremedicine.com. 请问各位大佬文章接收后收到编辑发来的邮件说要这个东西，要怎么弄，这个表格去哪里下载。

102 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1103727, encodeId=cf7b1103e27fa, content=选刊时有哪些需要避免的雷区？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103728, encodeId=b3691103e28d8, content=哪些期刊是公认的水刊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080559, encodeId=b1481080559a3, content=偏重的研究方向：生物信息学 经验分享：拒稿率高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16645573724, createdName=yongshuang, createdTime=Thu Dec 16 08:58:35 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014215, encodeId=5e6c101421588, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：表观遗传;生信 经验分享：想知道不加速的话全流程得多久啊····, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=24591642868, createdName=sunnysx, createdTime=Fri Sep 03 09:39:18 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579984, encodeId=13c85e998471, content=不开放获取可以不交版面费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06a41689219, createdName=momoxiaogu, createdTime=Sat Nov 16 00:00:00 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944688, encodeId=c2469446887d, content=请问各位，如果没选择加速出版的话一般一审多久？我1月份投稿，未选择加速出版和开源，投稿一周后状态从under consideration变成under review，现在under review状态持续差不多四周了，还是一点动静没有。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78ee5383123, createdName=ms7000000876347523, createdTime=Tue Mar 02 10:25:13 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=949586, encodeId=1c839495860a, content=请问各位大神，投稿5天，一直处于under consideration~是怎么个意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e3ad5471158, createdName=ms2000001884403772, createdTime=Fri Mar 19 21:23:49 CST 2021, time=2021-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905919, encodeId=8356905919c0, content=Please amend the author disclosure form to complete section 8 and return this to the journal via email (c.brady@futuremedicine.com. 请问各位大佬文章接收后收到编辑发来的邮件说要这个东西，要怎么弄，这个表格去哪里下载。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bd685266604, createdName=一年发三篇, createdTime=Tue Dec 08 09:53:16 CST 2020, time=2020-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=809982, encodeId=960a809982df, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：主要内容是表观遗传，加小的实验验证 2020.5.11-投稿，选择了加速 2020.5.28-修回R1-小修-一周内修回 2020.6.5-修回去 2020.6.11-再次修回R2,小修，主要是修改文章里面的试剂厂家以及个别语句 2020.6.14修回去 2020.6.16 接收，让交钱 2020.6.23发给proof（无图片，说图片正在修），让修改 2020.6.24修改好了proof，提交了 2020.7.1，说缺少了一张图figure 5，让补充，由于老板没及时check邮件，7.9号发给我，在7.9号补充，返回去了 2020.7.18，再次给了proof，带上了图片 2020.7.18，proof基本没问题就提交了 2020.7.23，online 历经2个多月，供大家参考！<a href='/topic/show?id=4f77e665253' target=_blank style='color:#2F92EE;'><a href='/topic/show?id=4f77e665253' target=_blank style='color:#2F92EE;'>#糖尿病#</a></a><a href='/topic/show?id=4f77e665253' target=_blank style='color:#2F92EE;'><a href='/topic/show?id=4f77e665253' target=_blank style='color:#2F92EE;'>#糖尿病#</a></a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=750, replyNumber=8, topicName=null, topicId=null, topicList=[TopicDto(id=76652, encryptionId=4f77e665253, topicName=糖尿病)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/SHS7K7Rw2Xj3oIen70BqdRFHOB0Y2iaQ14FZw2TCsgCVD3dL2xAQ38zAshDcFPWhNtFPDXCZo9libNK4wqT2Cicgw/132, createdBy=de1b5291100, createdName=With_yan, createdTime=Tue Aug 18 08:27:36 CST 2020, time=2020-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591318, encodeId=efdc591318e6, content=只要能快点审完就行With_yan 2020-05-20 发表:: 我是5.11提交的，一开始是under consideration，现在是under review，under review这个状态两三天了。很奇怪为啥咱们不一样With_yan 2020-05-20 00:00:00 发表: 我是5.11提交的，一开始是under consideration，现在是under review，under review这个状态两三天了。很奇怪为啥咱们不一样, beContent=With_yan 2020-05-20 发表:: 我是5.11提交的，一开始是under consideration，现在是under review，under review这个状态两三天了。很奇怪为啥咱们不一样, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24355093072, createdName=145d9400m83暂无昵称, createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=)]

2020-08-18 With_yan

审稿速度:1.0 | 投稿命中率:50.0
经验分享：主要内容是表观遗传，加小的实验验证 2020.5.11-投稿，选择了加速 2020.5.28-修回R1-小修-一周内修回 2020.6.5-修回去 2020.6.11-再次修回R2,小修，主要是修改文章里面的试剂厂家以及个别语句 2020.6.14修回去 2020.6.16 接收，让交钱 2020.6.23发给proof（无图片，说图片正在修），让修改 2020.6.24修改好了proof，提交了 2020.7.1，说缺少了一张图figure 5，让补充，由于老板没及时check邮件，7.9号发给我，在7.9号补充，返回去了 2020.7.18，再次给了proof，带上了图片 2020.7.18，proof基本没问题就提交了 2020.7.23，online 历经2个多月，供大家参考！#糖尿病##糖尿病#

750 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=1103727, encodeId=cf7b1103e27fa, content=选刊时有哪些需要避免的雷区？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103728, encodeId=b3691103e28d8, content=哪些期刊是公认的水刊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080559, encodeId=b1481080559a3, content=偏重的研究方向：生物信息学 经验分享：拒稿率高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16645573724, createdName=yongshuang, createdTime=Thu Dec 16 08:58:35 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014215, encodeId=5e6c101421588, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：表观遗传;生信 经验分享：想知道不加速的话全流程得多久啊····, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=24591642868, createdName=sunnysx, createdTime=Fri Sep 03 09:39:18 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579984, encodeId=13c85e998471, content=不开放获取可以不交版面费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06a41689219, createdName=momoxiaogu, createdTime=Sat Nov 16 00:00:00 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944688, encodeId=c2469446887d, content=请问各位，如果没选择加速出版的话一般一审多久？我1月份投稿，未选择加速出版和开源，投稿一周后状态从under consideration变成under review，现在under review状态持续差不多四周了，还是一点动静没有。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78ee5383123, createdName=ms7000000876347523, createdTime=Tue Mar 02 10:25:13 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=949586, encodeId=1c839495860a, content=请问各位大神，投稿5天，一直处于under consideration~是怎么个意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e3ad5471158, createdName=ms2000001884403772, createdTime=Fri Mar 19 21:23:49 CST 2021, time=2021-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905919, encodeId=8356905919c0, content=Please amend the author disclosure form to complete section 8 and return this to the journal via email (c.brady@futuremedicine.com. 请问各位大佬文章接收后收到编辑发来的邮件说要这个东西，要怎么弄，这个表格去哪里下载。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bd685266604, createdName=一年发三篇, createdTime=Tue Dec 08 09:53:16 CST 2020, time=2020-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=809982, encodeId=960a809982df, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：主要内容是表观遗传，加小的实验验证 2020.5.11-投稿，选择了加速 2020.5.28-修回R1-小修-一周内修回 2020.6.5-修回去 2020.6.11-再次修回R2,小修，主要是修改文章里面的试剂厂家以及个别语句 2020.6.14修回去 2020.6.16 接收，让交钱 2020.6.23发给proof（无图片，说图片正在修），让修改 2020.6.24修改好了proof，提交了 2020.7.1，说缺少了一张图figure 5，让补充，由于老板没及时check邮件，7.9号发给我，在7.9号补充，返回去了 2020.7.18，再次给了proof，带上了图片 2020.7.18，proof基本没问题就提交了 2020.7.23，online 历经2个多月，供大家参考！<a href='/topic/show?id=4f77e665253' target=_blank style='color:#2F92EE;'><a href='/topic/show?id=4f77e665253' target=_blank style='color:#2F92EE;'>#糖尿病#</a></a><a href='/topic/show?id=4f77e665253' target=_blank style='color:#2F92EE;'><a href='/topic/show?id=4f77e665253' target=_blank style='color:#2F92EE;'>#糖尿病#</a></a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=750, replyNumber=8, topicName=null, topicId=null, topicList=[TopicDto(id=76652, encryptionId=4f77e665253, topicName=糖尿病)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/SHS7K7Rw2Xj3oIen70BqdRFHOB0Y2iaQ14FZw2TCsgCVD3dL2xAQ38zAshDcFPWhNtFPDXCZo9libNK4wqT2Cicgw/132, createdBy=de1b5291100, createdName=With_yan, createdTime=Tue Aug 18 08:27:36 CST 2020, time=2020-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591318, encodeId=efdc591318e6, content=只要能快点审完就行With_yan 2020-05-20 发表:: 我是5.11提交的，一开始是under consideration，现在是under review，under review这个状态两三天了。很奇怪为啥咱们不一样With_yan 2020-05-20 00:00:00 发表: 我是5.11提交的，一开始是under consideration，现在是under review，under review这个状态两三天了。很奇怪为啥咱们不一样, beContent=With_yan 2020-05-20 发表:: 我是5.11提交的，一开始是under consideration，现在是under review，under review这个状态两三天了。很奇怪为啥咱们不一样, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24355093072, createdName=145d9400m83暂无昵称, createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=)]

2020-05-20 145d9400m83暂无昵称

只要能快点审完就行With_yan 2020-05-20 发表::
我是5.11提交的，一开始是under consideration，现在是under review，under review这个状态两三天了。很奇怪为啥咱们不一样With_yan 2020-05-20 00:00:00 发表:
我是5.11提交的，一开始是under consideration，现在是under review，under review这个状态两三天了。很奇怪为啥咱们不一样

With_yan 2020-05-20 发表:: 我是5.11提交的，一开始是under consideration，现在是under review，under review这个状态两三天了。很奇怪为啥咱们不一样

123 2

展开2条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务